Page 1164 - Hematology_ Basic Principles and Practice ( PDFDrive )

1019.e4 Part VII Hematologic Malignancies

134. Raimondi SC, Behm FG, Roberson PK, et al: Cytogenetics of pre- 154. Inaba T, Inukai T, Yoshihara T, et al: Reversal of apoptosis by the
B-cell acute lymphoblastic leukemia with emphasis on prognostic leukaemia-associated E2A-HLF chimaeric transcription factor. Nature
implications of the t(1;19). J Clin Oncol 8(8):1380–1388, 1990. 382(6591):541–544, 1996.
135. Nourse J, Mellentin JD, Galili N, et al: Chromosomal translocation 155. Metzstein MM, Hengartner MO, Tsung N, et al: Transcriptional
t(1;19) results in synthesis of a homeobox fusion mRNA that codes for regulator of programmed cell death encoded by Caenorhabditis elegans
a potential chimeric transcription factor. Cell 60(4):535–545, 1990. gene ces-2. Nature 382(6591):545–547, 1996.
136. Kamps MP, Murre C, Sun XH, et al: A new homeobox gene contributes 156. Thompson CB: Transcription. A fate worse than death. Nature
the DNA binding domain of the t(1;19) translocation protein in pre-B 382(6591):492–493, 1996.
ALL. Cell 60(4):547–555, 1990. 157. Inukai T, Inoue A, Kurosawa H, et al: SLUG, a ces-1-related zinc finger
137. Mellentin JD, Nourse J, Hunger SP, et al: Molecular analysis of the transcription factor gene with antiapoptotic activity, is a downstream
t(1;19) breakpoint cluster region in pre-B cell acute lymphoblastic target of the E2A-HLF oncoprotein. Mol Cell 4(3):343–352, 1999.
leukemias. Genes Chromosomes Cancer 2(3):239–247, 1990. 158. Metzstein MM, Horvitz HR: The C. elegans cell death specifica-
138. Van Dijk MA, Voorhoeve PM, Murre C: Pbx1 is converted into a tion gene ces-1 encodes a snail family zinc finger protein. Mol Cell
transcriptional activator upon acquiring the N-terminal region of E2A 4(3):309–319, 1999.
in pre-B-cell acute lymphoblastoid leukemia. Proc Natl Acad Sci USA 159. Inoue A, Seidel MG, Wu W, et al: Slug, a highly conserved zinc
90(13):6061–6065, 1993. finger transcriptional repressor, protects hematopoietic progenitor cells
139. LeBrun DP, Cleary ML: Fusion with E2A alters the transcriptional from radiation-induced apoptosis in vivo. Cancer Cell 2(4):279–288,
properties of the homeodomain protein PBX1 in t(1;19) leukemias. 2002.
Oncogene 9(6):1641–1647, 1994. 160. Wu WS, Heinrichs S, Xu D, et al: Slug antagonizes p53-mediated
140. Lu Q, Wright DD, Kamps MP: Fusion with E2A converts the Pbx1 apoptosis of hematopoietic progenitors by repressing puma. Cell
homeodomain protein into a constitutive transcriptional activator in 123(4):641–653, 2005.
human leukemias carrying the t(1;19) translocation. Mol Cell Biol 161. Dreyling MH, Martinez-Climent JA, Zheng M, et al: The t(10;11)
14(6):3938–3948, 1994. (p13;q14) in the U937 cell line results in the fusion of the AF10
141. Kamps MP, Baltimore D: E2A-Pbx1, the t(1;19) translocation protein gene and CALM, encoding a new member of the AP-3 clathrin
of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid assembly protein family. Proc Natl Acad Sci USA 93(10):4804–4809,
leukemia in mice. Mol Cell Biol 13(1):351–357, 1993. 1996.
142. Dedera DA, Waller EK, LeBrun DP, et al: Chimeric homeobox gene 162. Asnafi V, Radford-Weiss I, Dastugue N, et al: CALM-AF10 is a
E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas common fusion transcript in T-ALL and is specific to the TCRgam-
in transgenic mice. Cell 74(5):833–843, 1993. madelta lineage. Blood 102(3):1000–1006, 2003.
143. Monica K, LeBrun DP, Dedera DA, et al: Transformation properties of 163. Okada Y, Jiang Q, Lemieux M, et al: Leukaemic transformation by
the E2a-Pbx1 chimeric oncoprotein: fusion with E2a is essential, but the CALM-AF10 involves upregulation of Hoxa5 by hDOT1L. Nat Cell
Pbx1 homeodomain is dispensable. Mol Cell Biol 14(12):8304–8314, Biol 8(9):1017–1024, 2006.
1994. 164. Deshpande AJ, Cusan M, Rawat VP, et al: Acute myeloid leukemia
144. Kamps MP, Wright DD, Lu Q: DNA-binding by oncoprotein E2a- is propagated by a leukemic stem cell with lymphoid characteristics
Pbx1 is important for blocking differentiation but dispensable for in a mouse model of CALM/AF10-positive leukemia. Cancer Cell
fibroblast transformation. Oncogene 12(1):19–30, 1996. 10(5):363–374, 2006.
145. Crist WM, Carroll AJ, Shuster JJ, et al: Poor prognosis of children 165. Lin YH, Kakadia PM, Chen Y, et al: Global reduction of the epigenetic
with pre-B acute lymphoblastic leukemia is associated with the t(1;19) H3K79 methylation mark and increased chromosomal instability in
(q23;p13): a Pediatric Oncology Group study. Blood 76(1):117–122, CALM-AF10-positive leukemias. Blood 114(3):651–658, 2009.
1990. 166. Chen L, Deshpande AJ, Banka D, et al: Abrogation of MLL-AF10 and
146. Pui CH, Crist WM: Cytogenetic abnormalities in childhood acute CALM-AF10-mediated transformation through genetic inactivation or
lymphoblastic leukemia correlates with clinical features and treatment pharmacological inhibition of the H3K79 methyltransferase Dot1l.
outcome. Leuk Lymphoma 7(4):259–274, 1992. Leukemia 27(4):813–822, 2013.
147. Rivera GK, Raimondi SC, Hancock ML, et al: Improved outcome in 167. Greaves MF, Wiemels J: Origins of chromosome translocations in
childhood acute lymphoblastic leukaemia with reinforced early treatment childhood leukaemia. Nat Rev Cancer 3(9):639–649, 2003.
and rotational combination chemotherapy. Lancet 337(8733):61–66, 168. Greaves MF, Maia AT, Wiemels JL, et al: Leukemia in twins: lessons in
1991. natural history. Blood 102(7):2321–2333, 2003.
148. Uckun FM, Sensel MG, Sather HN, et al: Clinical significance of 169. Mori H, Colman SM, Xiao Z, et al: Chromosome translocations and
translocation t(1;19) in childhood acute lymphoblastic leukemia in the covert leukemic clones are generated during normal fetal development.
context of contemporary therapies: a report from the Children’s Cancer Proc Natl Acad Sci USA 99(12):8242–8247, 2002.
Group. J Clin Oncol 16(2):527–535, 1998. 170. Golub TR, Barker GF, Stegmaier K, et al: The TEL gene contributes
149. Hunger SP, Ohyashiki K, Toyama K, et al: Hlf, a novel hepatic bZIP to the pathogenesis of myeloid and lymphoid leukemias by diverse
protein, shows altered DNA-binding properties following fusion to E2A molecular genetic mechanisms. Curr Top Microbiol Immunol 220:67–79,
in t(17;19) acute lymphoblastic leukemia. Genes Dev 6(9):1608–1620, 1997.
1992. 171. Hock H, Meade E, Medeiros S, et al: Tel/Etv6 is an essential and
150. Inaba T, Roberts WM, Shapiro LH, et al: Fusion of the leucine zipper selective regulator of adult hematopoietic stem cell survival. Genes Dev
gene HLF to the E2A gene in human acute B-lineage leukemia. Science 18(19):2336–2341, 2004.
257(5069):531–534, 1992. 172. Cave H, Cacheux V, Raynaud S, et al: ETV6 is the target of chromo-
151. Yoshihara T, Inaba T, Shapiro LH, et al: E2A-HLF-mediated cell some 12p deletions in t(12;21) childhood acute lymphocytic leukemia.
transformation requires both the trans-activation domains of E2A Leukemia 11(9):1459–1464, 1997.
and the leucine zipper dimerization domain of HLF. Mol Cell Biol 173. Jousset C, Carron C, Boureux A, et al: A domain of TEL conserved
15(6):3247–3255, 1995. in a subset of ETS proteins defines a specific oligomerization interface
152. Ito C, Kumagai M, Manabe A, et al: Hyperdiploid acute lymphoblastic essential to the mitogenic properties of the TEL-PDGFR beta oncop-
leukemia with 51 to 65 chromosomes: a distinct biological entity with rotein. EMBO J 16(1):69–82, 1997.
a marked propensity to undergo apoptosis. Blood 93(1):315–320, 174. McLean TW, Ringold S, Neuberg D, et al: TEL/AML-1 dimerizes and
1999. is associated with a favorable outcome in childhood acute lymphoblastic
153. Honda H, Inaba T, Suzuki T, et al: Expression of E2A-HLF chimeric leukemia. Blood 88(11):4252–4258, 1996.
protein induced T-cell apoptosis, B-cell maturation arrest, and devel- 175. Takeuchi S, Seriu T, Bartram CR, et al: TEL is one of the targets for
opment of acute lymphoblastic leukemia. Blood 93(9):2780–2790, deletion on 12p in many cases of childhood B-lineage acute lympho-
1999. blastic leukemia. Leukemia 11(8):1220–1223, 1997.